Pulmonary Pathology of Early COVID-19
Pulmonary & Respiratory Medicine is pleased to announce Special issue on “Pulmonary Pathology of Early COVID-19”.
Following an outbreak of pneumonia without a clear cause in the city of Wuhan in China, a novel strain of coronavirus (2019-nCoV) was detected in December 2019.
Coronaviruses were identified in the mid-1960s and are known to infect humans and a variety of animals (including birds and mammals). Since 2002, two coronaviruses infecting animals have evolved and caused outbreaks in humans: SARS-CoV (Severe Acute Respiratory Syndrome) identified in southern China in 2003, and MERS-CoV (Middle East Respiratory Syndrome), identified in Saudi Arabia in 2012. Together, they have caused more than 1600 deaths.
It’s in these times of crisis where communities come together even more. In support of the global efforts in diagnosis, treatment, prevention and further research in this disease and similar viral respiratory infections. Our approach is to use the world-class information we have available to directly improve health and to support the virtual efforts of healthcare practitioners globally. We are continually monitoring the developments and we will update the content of this page periodically.
With the same purpose our Journal “Pulmonary & Respiratory Medicine” is announcing Special issue, We welcome both solicited and unsolicited submissions that will contribute to this special issue.
Journal is in the process of publishing a Special issue on
"Pulmonary Pathology of Early COVID-19"
so; we are inviting eminent personalities like you who have expertise in the field to frame up an outstanding informative issue for our readers.